Ipca Laboratories Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Ipca Laboratories Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 32% to $76,224,100,000. Profit margin reached 7%. Total operating expenses were $18,987,600,000.

Profit Margin

Ipca Laboratories Limited (NSE:IPCALAB.NS): Profit margin
2010 15.59B 2.05B 13.17%
2011 18.82B 2.62B 13.96%
2012 23.58B 2.77B 11.75%
2015 31.16B 2.59B 8.32%
2016 28.45B 967.3M 3.4%
2018 32.06B 2.39B 7.47%
2019 36.92B 4.44B 12.05%
2021 53.40B 11.40B 21.34%
2022 57.66B 8.84B 15.33%
2024 76.22B 5.47B 7.18%

IPCALAB.NS Income Statement (2010 – 2023)

2023 2021 2020 2018 2017 2015 2014 2012 2011 2010
Revenue
Revenue
76.22B57.66B53.40B36.92B32.06B28.45B31.16B23.58B18.82B15.59B
Cost of revenue
28.47B21.05B18.01B12.90B11.76B11.09B12.09B9.13B7.76B6.45B
Gross profit
47.74B36.60B35.39B24.01B20.30B17.35B19.06B14.45B11.06B9.13B
Operating exp.
Research and development
1.66B418M523.8M207.4M266.2M404.6M402.6M404.7M00
Selling and marketing
7.08B3.69B2.98B2.94B2.52B2.13B2.45B1.96B00
Total operating expenses
18.98B25.97B22.18B18.66B17.46B15.57B15.37B9.93B7.34B6.18B
Operating income
29.59B10.59B13.14B5.31B2.83B1.78B3.69B4.52B3.72B2.95B
Other income (expenses), net
-21.16B555M-9.72B150.1M69.4M-588.9M-90.9M-878.8M314M293.2M
Income before tax
8.42B11.35B13.81B5.46B2.90B1.15B3.61B3.64B3.40B2.66B
Income tax expense
3.13B2.24B2.40B1.04B511.1M185.7M1.01B881.1M783.8M627.2M
Net income
5.47B8.84B11.40B4.44B2.39B967.3M2.59B2.77B2.62B2.05B
Earnings per share
Basic EPS
21.5734.8545.0117.619.493.6910.0710.9820.9616.44
Diluted EPS
21.5734.8545.0117.619.493.6910.0710.9820.9516.41
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source